Recent Advances in Pediatric Cancer Research.


Journal

Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R

Informations de publication

Date de publication:
01 12 2021
Historique:
received: 15 04 2021
revised: 05 09 2021
accepted: 22 09 2021
pubmed: 26 9 2021
medline: 11 1 2022
entrez: 25 9 2021
Statut: ppublish

Résumé

Over the past few years, the field of pediatric cancer has experienced a shift in momentum, and this has led to new and exciting findings that have relevance beyond pediatric malignancies. Here we present the current status of key aspects of pediatric cancer research. We have focused on genetic and epigenetic drivers of disease, cellular origins of different pediatric cancers, disease models, the tumor microenvironment, and cellular immunotherapies.

Identifiants

pubmed: 34561271
pii: 0008-5472.CAN-21-1191
doi: 10.1158/0008-5472.CAN-21-1191
pmc: PMC9725930
mid: NIHMS1745031
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5783-5799

Subventions

Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States

Informations de copyright

©2021 American Association for Cancer Research.

Références

Nat Biotechnol. 2019 Jul;37(7):773-782
pubmed: 31061481
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
EMBO Mol Med. 2018 Dec;10(12):
pubmed: 30389682
Nat Commun. 2021 Feb 12;12(1):985
pubmed: 33579957
Oncotarget. 2016 Nov 8;7(45):72860-72867
pubmed: 27655679
Neurooncol Adv. 2020 Aug 08;2(1):vdaa095
pubmed: 32939452
Lancet Oncol. 2018 May;19(5):705-714
pubmed: 29606586
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34272305
Oncoimmunology. 2019 Jun 27;8(9):e1629779
pubmed: 31428529
Oncoimmunology. 2017 Apr 28;6(6):e1320626
pubmed: 28680756
Lancet Oncol. 2019 Jul;20(7):1011-1022
pubmed: 31151904
Sci Adv. 2020 Oct 23;6(43):
pubmed: 33097530
Nat Med. 2018 Feb;24(2):176-185
pubmed: 29334376
Open Biol. 2019 May 31;9(5):190056
pubmed: 31088252
Sci Transl Med. 2016 Nov 23;8(366):366ra161
pubmed: 27881822
Acta Neuropathol. 2019 Apr;137(4):637-655
pubmed: 30770999
JCO Precis Oncol. 2018;2018:
pubmed: 30027144
Annu Rev Genomics Hum Genet. 2019 Aug 31;20:241-263
pubmed: 31082280
Sci Transl Med. 2018 Jul 4;10(448):
pubmed: 29973406
Cancer Discov. 2021 Apr;11(4):858-873
pubmed: 33811121
Front Oncol. 2020 Oct 28;10:590033
pubmed: 33194750
Clin Cancer Res. 2018 Nov 15;24(22):5673-5684
pubmed: 29784674
PLoS One. 2009;4(3):e4932
pubmed: 19305498
Nat Commun. 2020 Mar 11;11(1):1310
pubmed: 32161258
N Engl J Med. 2016 Dec 29;375(26):2550-2560
pubmed: 28029918
Science. 2019 May 3;364(6439):485-491
pubmed: 31048490
Cell. 2020 Dec 23;183(7):1962-1985.e31
pubmed: 33242424
Stem Cell Reports. 2017 May 9;8(5):1408-1420
pubmed: 28494941
Nat Med. 2017 Apr;23(4):493-500
pubmed: 28263307
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
BMC Cancer. 2019 Sep 9;19(1):895
pubmed: 31500597
Acta Neuropathol Commun. 2018 Aug 15;6(1):80
pubmed: 30111355
Cancers (Basel). 2021 Aug 05;13(16):
pubmed: 34439115
PLoS One. 2020 Sep 25;15(9):e0237802
pubmed: 32976510
Virchows Arch. 2018 May;472(5):815-824
pubmed: 29445891
Nat Genet. 2017 Aug;49(8):1261-1266
pubmed: 28650485
J Natl Cancer Inst. 2021 Jul 1;113(7):875-883
pubmed: 33372952
J Clin Oncol. 2021 Sep 10;39(26):2859-2871
pubmed: 34166060
Cancer Biol Ther. 2016 Dec;17(12):1253-1265
pubmed: 27834580
J Pathol. 2017 May;242(1):102-112
pubmed: 28188619
Cell. 2020 Dec 10;183(6):1617-1633.e22
pubmed: 33259802
J Clin Oncol. 2016 Jul 1;34(19):2206-11
pubmed: 27001570
Lancet Child Adolesc Health. 2021 Feb;5(2):142-154
pubmed: 33484663
Cancer Discov. 2021 Jun;11(6):1454-1467
pubmed: 33563663
Cancer Cell. 2018 Mar 12;33(3):527-541.e8
pubmed: 29502955
Cancer Cell. 2014 Nov 10;26(5):668-681
pubmed: 25453903
Biopreserv Biobank. 2021 Apr;19(2):124-129
pubmed: 33493007
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
Nat Genet. 2019 Dec;51(12):1702-1713
pubmed: 31768071
Nature. 2020 Apr;580(7803):396-401
pubmed: 32296180
Cancer Discov. 2017 Aug;7(8):884-899
pubmed: 28446439
Curr Oncol Rep. 2019 Aug 15;21(10):85
pubmed: 31414239
Clin Cancer Res. 2017 Jun 1;23(11):e6-e13
pubmed: 28572262
Nat Neurosci. 2020 Jul;23(7):842-853
pubmed: 32424282
Acta Neuropathol Commun. 2020 Oct 28;8(1):173
pubmed: 33115534
Lancet Oncol. 2015 Dec;16(16):1659-66
pubmed: 26522332
Mol Oncol. 2018 Aug;12(8):1219-1232
pubmed: 28388012
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
Cancer Discov. 2018 Feb;8(2):164-173
pubmed: 29196463
J Clin Invest. 2019 Aug 5;129(9):3474-3481
pubmed: 31380804
Lancet Oncol. 2020 Apr;21(4):541-550
pubmed: 32192573
Cell. 2017 Sep 21;171(1):163-178.e19
pubmed: 28844694
Clin Cancer Res. 2018 Feb 15;24(4):939-949
pubmed: 29191970
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Nat Rev Immunol. 2009 Mar;9(3):162-74
pubmed: 19197294
Sci Rep. 2019 Jun 25;9(1):9211
pubmed: 31239476
Genes Dev. 2019 Jun 1;33(11-12):626-640
pubmed: 30975722
J Pediatr. 2021 Jul;234:172-180.e3
pubmed: 33684394
Am J Cancer Res. 2020 Feb 01;10(2):674-687
pubmed: 32195035
J Natl Cancer Inst. 2021 Apr 6;113(4):408-417
pubmed: 32894760
N Engl J Med. 2015 Dec 10;373(24):2336-2346
pubmed: 26580448
Nat Commun. 2020 Feb 21;11(1):1008
pubmed: 32081846
Cancer Immunol Res. 2016 Oct;4(10):869-880
pubmed: 27549124
Nat Rev Clin Oncol. 2021 Jun;18(6):363-378
pubmed: 33495553
Clin Cancer Res. 2017 Jun 1;23(11):e1-e5
pubmed: 28572261
Clin Cancer Res. 2016 Feb 1;22(3):582-95
pubmed: 26405194
Clin Epigenetics. 2015 Jul 09;7:62
pubmed: 26157508
Cancer Discov. 2018 Aug;8(8):944-957
pubmed: 29891538
Nat Commun. 2020 Nov 25;11(1):5992
pubmed: 33239635
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
Nat Commun. 2021 Feb 10;12(1):937
pubmed: 33568653
Acta Neuropathol Commun. 2016 May 27;4(1):54
pubmed: 27229157
EMBO Mol Med. 2020 Jul 7;12(7):e8662
pubmed: 32578942
N Engl J Med. 2020 Apr 9;382(15):1430-1442
pubmed: 32187457
Clin Cancer Res. 2020 Mar 15;26(6):1309-1317
pubmed: 31852832
Nature. 2017 Jul 19;547(7663):311-317
pubmed: 28726821
Br J Cancer. 2018 Aug;119(5):615-621
pubmed: 30131550
Nat Med. 2019 Sep;25(9):1408-1414
pubmed: 31477906
JAMA Oncol. 2017 May 01;3(5):636-651
pubmed: 28241208
Oncoimmunology. 2018 Sep 11;7(12):e1475873
pubmed: 30524885
Acta Neuropathol. 2021 Feb;141(2):281-290
pubmed: 33319313
J Immunother Cancer. 2021 May;9(5):
pubmed: 34021032
Curr Opin Hematol. 2019 Nov;26(6):427-433
pubmed: 31577606
Nature. 2017 Sep 7;549(7670):96-100
pubmed: 28854174
J Bone Oncol. 2019 Dec 02;20:100270
pubmed: 31890491
PLoS Genet. 2015 Feb 06;11(2):e1004951
pubmed: 25659124
Nat Genet. 2012 Jan 29;44(3):251-3
pubmed: 22286216
Nucleic Acids Res. 2019 Feb 20;47(3):1255-1267
pubmed: 30496486
Front Genet. 2020 May 19;11:493
pubmed: 32508881
Clin Cancer Res. 2019 Aug 1;25(15):4691-4700
pubmed: 30988079
Onco Targets Ther. 2020 Mar 17;13:2311-2317
pubmed: 32256082
Cancers (Basel). 2021 May 26;13(11):
pubmed: 34073340
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Nat Commun. 2020 May 15;11(1):2438
pubmed: 32415133
Nature. 2018 Mar 15;555(7696):371-376
pubmed: 29489755
Transl Oncol. 2021 Feb;14(2):100971
pubmed: 33321428
Cell Rep. 2019 Nov 5;29(6):1675-1689.e9
pubmed: 31693904
Curr Probl Cancer. 2021 Dec;45(6):100734
pubmed: 33865615
Acta Neuropathol. 2019 Feb;137(2):297-306
pubmed: 30460397
Cancer Med. 2020 Aug;9(16):5948-5959
pubmed: 32592321
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):
pubmed: 33500353
Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
pubmed: 5279523
Curr Biol. 2015 May 18;25(10):R397-9
pubmed: 25989073
Front Oncol. 2020 Jul 07;10:1000
pubmed: 32733795
Ann Oncol. 2020 Jun;31(6):745-759
pubmed: 33506766
Blood. 2019 Oct 10;134(15):1227-1237
pubmed: 31350265
Cancer Immunol Res. 2019 Sep;7(9):1401-1411
pubmed: 31266783
Neuron. 2019 Feb 6;101(3):472-485.e7
pubmed: 30638745
J Natl Cancer Inst. 2019 Sep 1;111(9):970-982
pubmed: 30698726
JCO Precis Oncol. 2021 Jan 11;5:
pubmed: 34095712
Nat Genet. 2015 Aug;47(8):864-71
pubmed: 26121087
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3696-3701
pubmed: 28325870
Cancer Res. 2018 Nov 1;78(21):6297-6307
pubmed: 30115695
Eur J Hum Genet. 2021 Aug;29(8):1301-1311
pubmed: 33840814
Br J Cancer. 2020 Mar;122(7):1077-1084
pubmed: 32015512
Nat Commun. 2019 Jun 3;10(1):2410
pubmed: 31160587
Cancer Discov. 2017 Mar;7(3):288-301
pubmed: 28213356
Nat Commun. 2019 Nov 25;10(1):5348
pubmed: 31767839
Clin Cancer Res. 2019 Dec 1;25(23):7126-7138
pubmed: 31484667
Cell. 2018 Apr 5;173(2):355-370.e14
pubmed: 29625052
Nature. 2020 Feb;578(7793):39-40
pubmed: 32025004
Cancer Discov. 2014 Feb;4(2):216-31
pubmed: 24436047
Nat Rev Cancer. 2018 Jul;18(7):407-418
pubmed: 29692415
Nat Commun. 2019 Jul 19;10(1):3240
pubmed: 31324872
JAMA Oncol. 2020 May 1;6(5):724-734
pubmed: 32191290
Life Sci Alliance. 2020 Dec 23;4(2):
pubmed: 33361335
Clin Cancer Res. 2017 Jun 1;23(11):e32-e37
pubmed: 28572265
Clin Cancer Res. 2017 Jun 1;23(11):e38-e45
pubmed: 28572266
Sci Transl Med. 2014 May 21;6(237):237ra67
pubmed: 24848257
Cancer Cell. 2019 Jan 14;35(1):140-155.e7
pubmed: 30595505
PLoS One. 2020 Sep 3;15(9):e0237792
pubmed: 32881892
Carcinogenesis. 2016 Jun;37(6):576-582
pubmed: 27207662
Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e410-e414
pubmed: 33526401
Cell. 2013 Mar 28;153(1):71-85
pubmed: 23540691
Cancer Immunol Res. 2017 Jul;5(7):547-559
pubmed: 28515123
Cancer Cell. 2020 Apr 13;37(4):569-583.e5
pubmed: 32289278
JCO Precis Oncol. 2021 Jan 14;1:
pubmed: 34036219
Nat Med. 2020 Nov;26(11):1742-1753
pubmed: 33020650
Oncoimmunology. 2017 Aug 24;6(9):e1331193
pubmed: 28932633
Cancer. 2017 Oct 1;123(19):3807-3815
pubmed: 28608950
Nat Commun. 2018 Aug 9;9(1):3184
pubmed: 30093639
Mol Aspects Med. 2020 Apr;72:100819
pubmed: 31563277
Nat Commun. 2019 Mar 19;10(1):1262
pubmed: 30890717
Science. 2015 Apr 3;348(6230):74-80
pubmed: 25838376
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Clin Cancer Res. 2019 May 1;25(9):2915-2924
pubmed: 30617136
Genet Med. 2017 Aug;19(8):955-958
pubmed: 28125078
Nat Commun. 2020 Aug 28;11(1):4324
pubmed: 32859926
Mol Oncol. 2021 Feb;15(2):364-380
pubmed: 33252831
Hum Pathol. 2017 Mar;61:130-139
pubmed: 27993576
J Pediatr Urol. 2020 Jun;16(3):376.e1-376.e8
pubmed: 32299765
Genome Med. 2020 Jul 31;12(1):67
pubmed: 32731881
Nat Commun. 2017 Dec 19;8(1):2126
pubmed: 29259247
Cancer Immunol Immunother. 2021 Jul;70(7):1979-1993
pubmed: 33416942
Int J Cancer. 2018 Apr 15;142(8):1594-1601
pubmed: 29210060
Nat Commun. 2020 Oct 27;11(1):5376
pubmed: 33110059
Nat Med. 2017 Apr;23(4):483-492
pubmed: 28263309
NPJ Precis Oncol. 2021 Mar 2;5(1):15
pubmed: 33654267
Eur J Cancer. 2019 Sep;119:151-157
pubmed: 31442817
Lancet Oncol. 2018 Jun;19(6):785-798
pubmed: 29753700
Nat Commun. 2019 Dec 20;10(1):5829
pubmed: 31863004
J Gastrointest Oncol. 2019 Oct;10(5):831-840
pubmed: 31602320
Elife. 2020 Aug 03;9:
pubmed: 32744500
Nat Commun. 2020 Dec 10;11(1):6322
pubmed: 33303760
Nature. 2019 Aug;572(7767):74-79
pubmed: 31341285
Clin Cancer Res. 2017 Jun 1;23(11):e14-e22
pubmed: 28572263
Lancet Oncol. 2020 Jan;21(1):121-133
pubmed: 31812554
Blood. 2020 Jan 30;135(5):387-391
pubmed: 31725148
J Clin Oncol. 2021 May 20;39(15):1650-1659
pubmed: 33764809
Commun Biol. 2020 Jul 9;3(1):363
pubmed: 32647372
Nat Commun. 2020 Nov 16;11(1):5823
pubmed: 33199677
Pediatr Hematol Oncol. 2019 Feb;36(1):17-27
pubmed: 30870043
Clin Cancer Res. 2016 Aug 1;22(15):3849-59
pubmed: 26957560
Cancer Immunol Immunother. 2016 Aug;65(8):995-1002
pubmed: 27369431
Science. 2020 Jul 3;369(6499):
pubmed: 32345712
Nature. 2012 Jan 29;482(7384):226-31
pubmed: 22286061
Eur J Cancer. 2012 Jan;48(2):237-42
pubmed: 22030452
Clin Cancer Res. 2016 Aug 1;22(15):3810-20
pubmed: 26994145
Mol Ther. 2017 Sep 6;25(9):2214-2224
pubmed: 28602436
J Natl Cancer Inst. 2019 Nov 1;111(11):1192-1201
pubmed: 30793172
J Clin Oncol. 2015 Feb 20;33(6):602-9
pubmed: 25584008
Int J Mol Sci. 2019 Nov 20;20(23):
pubmed: 31757062
Clin Cancer Res. 2020 Aug 1;26(15):4018-4030
pubmed: 32332015
J Clin Oncol. 2018 Feb 20;36(6):591-599
pubmed: 29300620
Clin Cancer Res. 2017 Jul 1;23(13):e91-e97
pubmed: 28674117
Nat Commun. 2020 May 5;11(1):2206
pubmed: 32371905
Nat Med. 2018 May;24(5):572-579
pubmed: 29662203
Acta Neuropathol Commun. 2017 Apr 17;5(1):28
pubmed: 28416018
Oncotarget. 2017 May 23;8(21):34141-34163
pubmed: 27191748
Pediatr Blood Cancer. 2020 May;67(5):e28098
pubmed: 31975571
Bone. 2020 Jan;130:115070
pubmed: 31525475
J Immunother Cancer. 2019 Oct 24;7(1):276
pubmed: 31651363
Oncotarget. 2017 Dec 22;9(5):6536-6549
pubmed: 29464090
Cancer Discov. 2019 Jan;9(1):46-63
pubmed: 30266815
J Immunother Cancer. 2020 Aug;8(2):
pubmed: 32788236
Acta Neuropathol Commun. 2018 Jun 28;6(1):51
pubmed: 29954445
J Hum Genet. 2020 Aug;65(8):667-674
pubmed: 32296131
Sci Transl Med. 2020 Nov 25;12(571):
pubmed: 33239386
Cancer Cell. 2020 Nov 9;38(5):716-733.e6
pubmed: 32946775
Sci Adv. 2021 Feb 5;7(6):
pubmed: 33547074
Nat Med. 2018 Nov;24(11):1752-1761
pubmed: 30349086
iScience. 2020 May 22;23(5):101103
pubmed: 32416589
Cancer Cell. 2016 Mar 14;29(3):379-393
pubmed: 26923874
Nat Cancer. 2021 Mar;2:357-365
pubmed: 34308366
Acta Neuropathol. 2020 Aug;140(2):209-225
pubmed: 32519082
Neuro Oncol. 2020 Jun 9;22(6):864-874
pubmed: 31970404
Genome Biol. 2017 Nov 15;18(1):220
pubmed: 29141660
Clin Cancer Res. 2016 Mar 15;22(6):1364-70
pubmed: 26534966
Cancer Cell. 2018 Jun 11;33(6):1128-1141.e7
pubmed: 29861296
Science. 2018 Aug 10;361(6402):594-599
pubmed: 30093597
Neoplasia. 2017 Mar;19(3):237-249
pubmed: 28254151
Sci Adv. 2020 Oct 16;6(42):
pubmed: 33067228
J Clin Oncol. 2020 Jan 1;38(1):43-50
pubmed: 31609649
JCO Precis Oncol. 2020 Oct 2;4:
pubmed: 33163847
Cell Rep. 2015 Feb 24;10(7):1082-95
pubmed: 25704812
Clin Cancer Res. 2017 Jun 1;23(11):e23-e31
pubmed: 28572264
Nat Commun. 2021 Jan 8;12(1):192
pubmed: 33420019
Cancers (Basel). 2020 Sep 18;12(9):
pubmed: 32962010
Nat Commun. 2014 Jun 03;5:3964
pubmed: 24888982
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11306-11311
pubmed: 27655895
Neuro Oncol. 2019 Jan 1;21(1):83-94
pubmed: 30169876
Cancer Cell. 2016 Dec 12;30(6):891-908
pubmed: 27960086
Cancer Immunol Immunother. 2020 Nov;69(11):2333-2343
pubmed: 32514618
Expert Rev Clin Pharmacol. 2019 Oct;12(10):931-939
pubmed: 31469968
Front Oncol. 2020 Dec 14;10:596191
pubmed: 33381456
Mol Ther Oncolytics. 2018 Nov 06;11:127-137
pubmed: 30581986

Auteurs

Troy A McEachron (TA)

Pediatric Oncology Branch, NCI, Bethesda, Maryland. Troy.McEachron@NIH.gov.

Lee J Helman (LJ)

Osteosarcoma Institute, Dallas, Texas.
Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH